OBJECTIVE: Schizophrenia (SZ) and bipolar disorder (BD) are heritable, polygenic disorders with shared clinical characteristics and genetic risk indicating a psychosis continuum. This is the first study using polygenic risk score (PGRS) to investigate the localization of diagnostic subcategories along the entire psychosis spectrum. METHOD: Based on results from the Psychiatric Genomics Consortium (PGC), we assigned a SZ and BD PGRS to each individual in our independent sample [N=570 BD spectrum cases, 452 SZ spectrum cases and 415 healthy controls (CTR)]. Potential differences in mean SZ and BD PGRS across diagnostic spectrums and subcategories were explored. RESULTS: SZ and BD PGRSs were significantly associated with both SZ and BD spectrums compared with CTR. For the subcategories, SZ PGRS was significantly associated with SZ, schizoaffective disorder, psychosis not otherwise specified, and BD1, while BD PGRS was significantly associated with BD1 and BD2. There were no significant differences between any of the diagnostic spectrums or subgroups for neither the SZ nor BD PGRS. Lifetime psychosis was significantly associated with SZ PGRS but not with BD PGRS. CONCLUSION: These findings further support the psychosis continuum model and provide molecular polygenetic validation of the localization of diagnostic subcategories within this continuum.
OBJECTIVE:Schizophrenia (SZ) and bipolar disorder (BD) are heritable, polygenic disorders with shared clinical characteristics and genetic risk indicating a psychosis continuum. This is the first study using polygenic risk score (PGRS) to investigate the localization of diagnostic subcategories along the entire psychosis spectrum. METHOD: Based on results from the Psychiatric Genomics Consortium (PGC), we assigned a SZ and BD PGRS to each individual in our independent sample [N=570 BD spectrum cases, 452 SZ spectrum cases and 415 healthy controls (CTR)]. Potential differences in mean SZ and BD PGRS across diagnostic spectrums and subcategories were explored. RESULTS: SZ and BD PGRSs were significantly associated with both SZ and BD spectrums compared with CTR. For the subcategories, SZ PGRS was significantly associated with SZ, schizoaffective disorder, psychosis not otherwise specified, and BD1, while BD PGRS was significantly associated with BD1 and BD2. There were no significant differences between any of the diagnostic spectrums or subgroups for neither the SZ nor BD PGRS. Lifetime psychosis was significantly associated with SZ PGRS but not with BD PGRS. CONCLUSION: These findings further support the psychosis continuum model and provide molecular polygenetic validation of the localization of diagnostic subcategories within this continuum.
Authors: Karolina Kauppi; Lars T Westlye; Martin Tesli; Francesco Bettella; Christine L Brandt; Morten Mattingsdal; Torill Ueland; Thomas Espeseth; Ingrid Agartz; Ingrid Melle; Srdjan Djurovic; Ole A Andreassen Journal: Schizophr Bull Date: 2014-11-11 Impact factor: 9.306
Authors: Dag Alnæs; Tobias Kaufmann; Dennis van der Meer; Aldo Córdova-Palomera; Jaroslav Rokicki; Torgeir Moberget; Francesco Bettella; Ingrid Agartz; Deanna M Barch; Alessandro Bertolino; Christine L Brandt; Simon Cervenka; Srdjan Djurovic; Nhat Trung Doan; Sarah Eisenacher; Helena Fatouros-Bergman; Lena Flyckt; Annabella Di Giorgio; Beathe Haatveit; Erik G Jönsson; Peter Kirsch; Martina J Lund; Andreas Meyer-Lindenberg; Giulio Pergola; Emanuel Schwarz; Olav B Smeland; Tiziana Quarto; Mathias Zink; Ole A Andreassen; Lars T Westlye Journal: JAMA Psychiatry Date: 2019-07-01 Impact factor: 21.596
Authors: Aldo Córdova-Palomera; Tobias Kaufmann; Francesco Bettella; Yunpeng Wang; Nhat Trung Doan; Dennis van der Meer; Dag Alnæs; Jaroslav Rokicki; Torgeir Moberget; Ida Elken Sønderby; Ole A Andreassen; Lars T Westlye Journal: Eur J Hum Genet Date: 2018-04-27 Impact factor: 4.246
Authors: Sarah M Hartz; Amy C Horton; Mary Oehlert; Caitlin E Carey; Arpana Agrawal; Ryan Bogdan; Li-Shiun Chen; Dana B Hancock; Eric O Johnson; Carlos N Pato; Michele T Pato; John P Rice; Laura J Bierut Journal: Biol Psychiatry Date: 2017-06-06 Impact factor: 13.382
Authors: C Laidi; M-A d'Albis; M Wessa; J Linke; M L Phillips; M Delavest; F Bellivier; A Versace; J Almeida; S Sarrazin; C Poupon; K Le Dudal; C Daban; N Hamdani; M Leboyer; J Houenou Journal: Acta Psychiatr Scand Date: 2014-11-28 Impact factor: 6.392
Authors: P H Lee; J T Baker; A J Holmes; N Jahanshad; T Ge; J-Y Jung; Y Cruz; D S Manoach; D P Hibar; J Faskowitz; K L McMahon; G I de Zubicaray; N G Martin; M J Wright; D Öngür; R Buckner; J Roffman; P M Thompson; J W Smoller Journal: Mol Psychiatry Date: 2016-10-11 Impact factor: 15.992
Authors: Roman Kotov; Katherine G Jonas; William T Carpenter; Michael N Dretsch; Nicholas R Eaton; Miriam K Forbes; Kelsie T Forbush; Kelsey Hobbs; Ulrich Reininghaus; Tim Slade; Susan C South; Matthew Sunderland; Monika A Waszczuk; Thomas A Widiger; Aidan G C Wright; David H Zald; Robert F Krueger; David Watson Journal: World Psychiatry Date: 2020-06 Impact factor: 49.548
Authors: Andrew J Schork; Yunpeng Wang; Wesley K Thompson; Anders M Dale; Ole A Andreassen Journal: Curr Opin Neurobiol Date: 2015-11-08 Impact factor: 6.627